G01N 2333/04
Varicella-zoster virus
G01N2333/04 (Varicella-zoster virus) appears on 125 US grants and 169 published applications in this corpus.
Search patents in G01N- Granted patents
- 125
- Published applications
- 169
- Assignees
- 74
- Inventors
- 254
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 4 |
| 2005 | 3 | 3 |
| 2006 | 2 | 5 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 2 |
| 2012 | 1 | 2 |
| 2013 | 2 | 2 |
| 2014 | 2 | 6 |
| 2015 | 1 | 7 |
| 2016 | 3 | 14 |
| 2017 | 3 | 7 |
| 2018 | 24 | 27 |
| 2019 | 14 | 9 |
| 2020 | 4 | 8 |
| 2021 | 5 | 16 |
| 2022 | 13 | 14 |
| 2023 | 3 | 20 |
| 2024 | 9 | 7 |
| 2025 | 4 | 4 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- High affinity engineered T-cell receptors targeting cmv infected cells9 Jun 2026US 12,649,772 B2Board of Regents, The University of Texas System
- Methods of selecting T cell line and donor thereof for adoptive cellular therapy27 Jan 2026US 12,533,407 B2Memorial Sloan Kettering Cancer Center
- Diagnosis of congenital cytomegalovirus infection23 Dec 2025US 12,504,429 B2Hadasit Medical Research Services and Development Ltd.
- Anti-varicella-zoster virus antibody9 Dec 2025US 12,491,386 B2Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses15 Apr 2025US 12,276,665 B2Aicuris Anti-Infective Cures GmbH
- Biosensors and methods for the determination of the monkeypox and chickenpox viruses belonging to the genus orthopoxvirus1 Oct 2026US 2026/0298927 A1Mugla Sitki Kocman Universitesi Strateji Gelistirme Daire Baskanligi
- Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy13 Aug 2026US 2026/0232793 A1Memorial Sloan Kettering Cancer Center
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Anti-microbial antibody signatures related to lung tumors and uses thereof9 Jul 2026US 2026/0194524 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Nucleic acid multimers and amplified nucleic acid hybridization assays using same674US 5,124,246 AChiron Corporation · 1992
- Nucleic acid-amplified immunoassay probes237US 5,656,731 AChiron Corporation · 1997
- Nucleic acid multimers and amplified nucleic acid hybridization assays using same139US 5,624,802 AChiron Corporation · 1997
- Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays56US 5,629,153 AChiron Corporation · 1997
- Peptides and combination of peptides for use in immunotherapy against various tumors45US 9,802,997 B2Immatics Biotechnologies GmbH · 2017